Wealthfront Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $19.6M | Sell |
43,918
-3,014
| -6% | -$1.34M | 0.05% | 119 |
|
2025
Q1 | $22.8M | Buy |
46,932
+5,913
| +14% | +$2.87M | 0.06% | 97 |
|
2024
Q4 | $16.5M | Buy |
41,019
+1,819
| +5% | +$733K | 0.05% | 118 |
|
2024
Q3 | $18.2M | Sell |
39,200
-490
| -1% | -$228K | 0.06% | 97 |
|
2024
Q2 | $18.6M | Sell |
39,690
-707
| -2% | -$331K | 0.06% | 87 |
|
2024
Q1 | $16.9M | Sell |
40,397
-263
| -0.6% | -$110K | 0.06% | 94 |
|
2023
Q4 | $16.5M | Sell |
40,660
-605
| -1% | -$246K | 0.06% | 84 |
|
2023
Q3 | $14.3M | Sell |
41,265
-356
| -0.9% | -$124K | 0.06% | 89 |
|
2023
Q2 | $14.6M | Buy |
41,621
+1,742
| +4% | +$613K | 0.06% | 84 |
|
2023
Q1 | $12.6M | Buy |
39,879
+4,883
| +14% | +$1.54M | 0.06% | 99 |
|
2022
Q4 | $10.1M | Sell |
34,996
-3,525
| -9% | -$1.02M | 0.05% | 114 |
|
2022
Q3 | $11.2M | Buy |
38,521
+4,596
| +14% | +$1.33M | 0.06% | 82 |
|
2022
Q2 | $9.56M | Buy |
33,925
+18,566
| +121% | +$5.23M | 0.05% | 97 |
|
2022
Q1 | $4.01M | Buy |
15,359
+8,236
| +116% | +$2.15M | 0.02% | 247 |
|
2021
Q4 | $1.56M | Buy |
7,123
+1,425
| +25% | +$313K | 0.01% | 431 |
|
2021
Q3 | $1.03M | Buy |
5,698
+26
| +0.5% | +$4.72K | ﹤0.01% | 465 |
|
2021
Q2 | $1.14M | Sell |
5,672
-3,869
| -41% | -$780K | 0.01% | 414 |
|
2021
Q1 | $2.05M | Buy |
9,541
+1,260
| +15% | +$271K | 0.01% | 260 |
|
2020
Q4 | $1.96M | Sell |
8,281
-930
| -10% | -$220K | 0.01% | 234 |
|
2020
Q3 | $2.51M | Sell |
9,211
-5
| -0.1% | -$1.36K | 0.02% | 144 |
|
2020
Q2 | $2.68M | Buy |
9,216
+930
| +11% | +$270K | 0.02% | 123 |
|
2020
Q1 | $1.97M | Buy |
8,286
+1,133
| +16% | +$270K | 0.02% | 146 |
|
2019
Q4 | $1.57M | Buy |
7,153
+597
| +9% | +$131K | 0.01% | 232 |
|
2019
Q3 | $1.11M | Sell |
6,556
-632
| -9% | -$107K | 0.01% | 270 |
|
2019
Q2 | $1.32M | Buy |
7,188
+213
| +3% | +$39.1K | 0.01% | 222 |
|
2019
Q1 | $1.28M | Buy |
6,975
+135
| +2% | +$24.8K | 0.01% | 214 |
|
2018
Q4 | $1.13M | Buy |
+6,840
| New | +$1.13M | 0.01% | 215 |
|